Robbins Geller Rudman & Dowd Llp
Recent News About Robbins Geller Rudman & Dowd Llp
-
Shareholder suit alleges Akorn, Fresenius merger benefits leadership, doesn't do enough for investors
A group of investors wants a court to keep German pharmaceutical firm Fresenius from buying Illinois drug maker Akorn, saying shareholders won’t get enough from the deal, which is valued at more than $4 billion.